Frederik Prip
Arhus, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Comprehensive genomic characterization of early-stage bladder cancer.
Journal: Nature genetics
Published: October 31, 2023
Single-nucleus and Spatially Resolved Intratumor Subtype Heterogeneity in Bladder Cancer.
Journal: European urology open science
Published: March 13, 2023
Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights.
Journal: European urology
Published: December 05, 2022
Author Correction: Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis.
Journal: Nature communications
Published: April 05, 2022
Elevated T-cell Exhaustion and Urinary Tumor DNA Levels Are Associated with Bacillus Calmette-Guérin Failure in Patients with Non-muscle-invasive Bladder Cancer.
Journal: European urology
Published: March 31, 2022
Immune Contexture and Differentiation Features Predict Outcome in Bladder Cancer.
Journal: European urology oncology
Published: September 28, 2021
Zoom in on Antibody Aggregates: A Potential Pitfall in the Search of Rare EV Populations.
Journal: Biomedicines
Published: December 18, 2020
STAG2 as a prognostic biomarker in low-grade non-muscle invasive bladder cancer.
Journal: Urologic oncology
Published: November 07, 2020
Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis.
Journal: Nature communications
Published: April 15, 2020
STAG2 Is a Biomarker for Prediction of Recurrence and Progression in Papillary Non-Muscle-Invasive Bladder Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 02, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026